Aarti Pharmalabs (NSE:AARTIPHARM) Net Issuance of Preferred Stock : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Aarti Pharmalabs's net issuance of preferred for the three months ended in Mar. 2025 was ₹0 Mil. The number is 0, which means that Aarti Pharmalabs has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Aarti Pharmalabs's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Aarti Pharmalabs Net Issuance of Preferred Stock Historical Data

The historical data trend for Aarti Pharmalabs's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Net Issuance of Preferred Stock Chart

Aarti Pharmalabs Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Net Issuance of Preferred Stock

Aarti Pharmalabs Quarterly Data
	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial									-	-	-	-	-

Aarti Pharmalabs Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Aarti Pharmalabs Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Pharmalabs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (NSE:AARTIPHARM) » Definitions » Net Issuance of Preferred Stock

Traded in Other Exchanges

543748:India

Address

Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080

Website

https://www.aartipharmalabs.com

Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines